Therefore, this study aimed to develop a machine learning-derived radiomics approach to discriminate the presence of EGFR, KRAS, ERBB2, and TP53 mutations on CT images in patients with NSCLC. This evidence concerns the gene TP53 and non-small cell lung carcinoma.